Intellectual Property India Publishes Patent Application for 'Cx3cr1-Binding Compounds, Uses Thereof And Related Methods' Filed by Ablynx N. V.; and Sanofi

MUMBAI, India, April 11 -- Intellectual Property India has published a patent application (202517012427 A) filed by Ablynx N. V.; and Sanofi, Gent, Belgium, on Feb. 13, for 'cx3cr1-binding compounds, uses thereof and related methods.'

Inventor(s) include Verhelst, Judith; Meoni, Paolo; and Lorent, Eric.

The application for the patent was published on April 11, under issue no. 15/2025.

According to the abstract released by the Intellectual Property India: "The present technology relates to a polypeptide comprising at least three immunoglobulin single variable domains (ISVDs). In particular, the present technology relates to a polypeptide comprising an optimized ISVD binding to fractalkine receptor CX3CR1 and an optimized ISVD binding to a...